Galera Therapeutics, Inc. ( GRTX) - Stock Earnings
GRTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
GRTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -1.4 million USD | — USD |
| 2025Q4 | 153.1 million USD | — USD |
| 2026Q1 | -1.6 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
GRTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -59.1 million USD | — USD |
| 2024 | -19.0 million USD | — USD |
| 2025 | 149.0 million USD | — USD |
| 2025 Est. | — | — |
GRTX
Price: $16.28
Earnings Per Share: 120.44 USD
P/E Ratio: 0.14
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 52746
Market Capitalization: 3.4 billion